150 related articles for article (PubMed ID: 15165692)
1. Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-beta formation.
Braak H; Del Tredici K
Neurobiol Aging; 2004 Jul; 25(6):713-8; discussion 743-6. PubMed ID: 15165692
[No Abstract] [Full Text] [Related]
2. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
Gouras GK; Almeida CG; Takahashi RH
Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263
[TBL] [Abstract][Full Text] [Related]
3. Amyloid beta peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology.
Kar S; Quirion R
Prog Brain Res; 2004; 145():261-74. PubMed ID: 14650921
[No Abstract] [Full Text] [Related]
4. Abeta-globulomers are formed independently of the fibril pathway.
Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer's filaments.
Inestrosa NC; Alvarez A; Calderón F
Mol Psychiatry; 1996 Nov; 1(5):359-61. PubMed ID: 9154226
[No Abstract] [Full Text] [Related]
6. The amyloid cascade hypothesis.
Korczyn AD
Alzheimers Dement; 2008 May; 4(3):176-8. PubMed ID: 18631966
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease. A new take on tau.
Marx J
Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
[No Abstract] [Full Text] [Related]
8. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.
MacDonald AB
Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667
[TBL] [Abstract][Full Text] [Related]
9. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease.
Crowther DC; Kinghorn KJ; Miranda E; Page R; Curry JA; Duthie FA; Gubb DC; Lomas DA
Neuroscience; 2005; 132(1):123-35. PubMed ID: 15780472
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of hnRNP B1 in the postmortem temporal cortices of patients with Alzheimer's disease.
Ishikawa M; Mizukami K; Iwakiri M; Kamma H; Ikonomovic MD; Dekosky ST; Asada T
Neurosci Res; 2004 Dec; 50(4):481-4. PubMed ID: 15567486
[TBL] [Abstract][Full Text] [Related]
12. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade.
Wirths O; Multhaup G; Bayer TA
J Neurochem; 2004 Nov; 91(3):513-20. PubMed ID: 15485483
[TBL] [Abstract][Full Text] [Related]
13. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
[TBL] [Abstract][Full Text] [Related]
14. [Alzheimer's disease and the proteins].
Morishima-Kawashima M; Saido TC; Ihara Y
Tanpakushitsu Kakusan Koso; 2001 Aug; 46(11 Suppl):1798-804. PubMed ID: 11579581
[No Abstract] [Full Text] [Related]
15. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
17. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
[TBL] [Abstract][Full Text] [Related]
18. [Oxidative stress, beta-amyloide peptide and Alzheimer's disease].
Manzano-León N; Mas-Oliva J
Gac Med Mex; 2006; 142(3):229-38. PubMed ID: 16875352
[TBL] [Abstract][Full Text] [Related]
19. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains.
Zhou XW; Li X; Bjorkdahl C; Sjogren MJ; Alafuzoff I; Soininen H; Grundke-Iqbal I; Iqbal K; Winblad B; Pei JJ
Neurobiol Dis; 2006 Jun; 22(3):657-68. PubMed ID: 16513361
[TBL] [Abstract][Full Text] [Related]
20. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]